JP5700740B1 - 固形医薬組成物 - Google Patents

固形医薬組成物 Download PDF

Info

Publication number
JP5700740B1
JP5700740B1 JP2014541239A JP2014541239A JP5700740B1 JP 5700740 B1 JP5700740 B1 JP 5700740B1 JP 2014541239 A JP2014541239 A JP 2014541239A JP 2014541239 A JP2014541239 A JP 2014541239A JP 5700740 B1 JP5700740 B1 JP 5700740B1
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
solid pharmaceutical
acid
mass
acidic substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2014541239A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2014174847A1 (ja
Inventor
内田　浩
浩 内田
真隆 花田
真隆 花田
義一 宮崎
義一 宮崎
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyorin Pharmaceutical Co Ltd
Original Assignee
Kyorin Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Pharmaceutical Co Ltd filed Critical Kyorin Pharmaceutical Co Ltd
Priority to JP2014541239A priority Critical patent/JP5700740B1/ja
Application granted granted Critical
Publication of JP5700740B1 publication Critical patent/JP5700740B1/ja
Publication of JPWO2014174847A1 publication Critical patent/JPWO2014174847A1/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2014541239A 2013-04-25 2014-04-24 固形医薬組成物 Active JP5700740B1 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2014541239A JP5700740B1 (ja) 2013-04-25 2014-04-24 固形医薬組成物

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2013092169 2013-04-25
JP2013092169 2013-04-25
JP2014541239A JP5700740B1 (ja) 2013-04-25 2014-04-24 固形医薬組成物
PCT/JP2014/002309 WO2014174847A1 (ja) 2013-04-25 2014-04-24 固形医薬組成物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015026203A Division JP6397778B2 (ja) 2013-04-25 2015-02-13 固形医薬組成物

Publications (2)

Publication Number Publication Date
JP5700740B1 true JP5700740B1 (ja) 2015-04-15
JPWO2014174847A1 JPWO2014174847A1 (ja) 2017-02-23

Family

ID=51791435

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2014541239A Active JP5700740B1 (ja) 2013-04-25 2014-04-24 固形医薬組成物
JP2015026203A Active JP6397778B2 (ja) 2013-04-25 2015-02-13 固形医薬組成物
JP2018164140A Active JP6689333B2 (ja) 2013-04-25 2018-09-03 固形医薬組成物

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2015026203A Active JP6397778B2 (ja) 2013-04-25 2015-02-13 固形医薬組成物
JP2018164140A Active JP6689333B2 (ja) 2013-04-25 2018-09-03 固形医薬組成物

Country Status (6)

Country Link
US (1) US9687453B2 (enExample)
EP (1) EP2990039A4 (enExample)
JP (3) JP5700740B1 (enExample)
CN (1) CN105338981B (enExample)
CA (1) CA2910121A1 (enExample)
WO (1) WO2014174847A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6018334B2 (ja) * 2014-10-23 2016-11-02 杏林製薬株式会社 固形医薬組成物

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105338982B (zh) 2013-04-25 2017-10-10 杏林制药株式会社 固体药用组合物
WO2016195020A1 (ja) * 2015-06-02 2016-12-08 杏林製薬株式会社 水性液剤
JP6031217B1 (ja) * 2015-06-02 2016-11-24 杏林製薬株式会社 水性液剤
WO2016195014A1 (ja) * 2015-06-02 2016-12-08 杏林製薬株式会社 水性液剤
MX2019014201A (es) * 2017-05-31 2020-01-23 Boehringer Ingelheim Int Composicion farmaceutica y forma de dosificacion farmaceutica que comprenden (e)-4-(2-(aminometil)-3-fluoroaliloxi)-n-ter-butilbenza mida, proceso para su preparacion, metodos de tratamiento y usos de las mismas.
SG11202001436YA (en) 2017-08-18 2020-03-30 Abbvie Inc Pharmaceutical formulations for treating endometriosis, uterine fibroids, polycystic ovary syndrome or adenomyosis
TW201912157A (zh) 2017-08-18 2019-04-01 美商艾伯維有限公司 治療子宮內膜異位症、子宮纖維瘤、多囊性卵巢症候群及子宮腺肌症之固體醫藥調配物
CN116410080B (zh) * 2021-12-31 2025-09-23 万华化学集团股份有限公司 一种异甲基紫罗兰酮生产废盐水中醋酸钾的回收方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005026147A1 (ja) * 2003-09-10 2005-03-24 Kyorin Pharmaceutical Co., Ltd. ７−（４−置換−３−シクロプロピルアミノメチル−１−ピロリジニル）キノロンカルボン酸誘導体
WO2013069297A1 (ja) * 2011-11-10 2013-05-16 杏林製薬株式会社 ７－｛（３s、４s）－３－［（シクロプロピルアミノ)メチル］－４－フルオロピロリジン－1－イル｝－６－フルオロ－１－（２－フルオロエチル）－８－メトキシ－４－オキソ－１、４－ジヒドロキノリン－３－カルボン酸の結晶
WO2013145750A1 (ja) * 2012-03-29 2013-10-03 杏林製薬株式会社 カプセル製剤
WO2013145749A1 (ja) * 2012-03-29 2013-10-03 杏林製薬株式会社 カプセル製剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8524001D0 (en) 1985-09-30 1985-11-06 Glaxo Group Ltd Pharmaceutical composition
AU3277899A (en) 1998-03-03 1999-09-20 Dae Woong Chemical Co., Ltd. Pharmaceutical composition containing cefuroxime axetil stable for moisture absorption
AT413647B (de) 1998-11-26 2006-04-15 Sandoz Ag Verwendung eines copolymerisats aus 1-vinyl-2-pyrrolidon und vinylacetat zur herstellung von cefuroximaxetil-hältigen tabletten
DE10048510A1 (de) 2000-09-29 2002-05-16 Fresenius Kabi De Gmbh Lagerstabile Infusionslösung des Ciprofloxacins mit verringertem Säuregehalt
ATE303149T1 (de) * 2001-02-27 2005-09-15 Ranbaxy Lab Ltd Orale pharmazeutische zusammensetzung aus cefpodoxim-proxetil
ES2297067T3 (es) 2003-03-19 2008-05-01 The Jordanian Pharmaceutical Manufacturing Co. Ltd. Composiciones farmaceuticas no higroscopicas que contienen acidos quinolinacarboxilicos de hidratados.
TW200612941A (en) 2004-07-02 2006-05-01 Daiichi Seiyaku Co Quinorone-containing pharmaceutical composition
US8969379B2 (en) 2004-09-17 2015-03-03 Eisai R&D Management Co., Ltd. Pharmaceutical compositions of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7=methoxy-6-quinolinecarboxide
EP1825866A4 (en) 2004-12-03 2008-03-12 Takeda Pharmaceutical SOLID PREPARATION
JP2006298811A (ja) 2005-04-20 2006-11-02 Taiyo Yakuhin Kogyo Kk ゲル化抑制製剤の設計
CN105338982B (zh) 2013-04-25 2017-10-10 杏林制药株式会社 固体药用组合物

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005026147A1 (ja) * 2003-09-10 2005-03-24 Kyorin Pharmaceutical Co., Ltd. ７−（４−置換−３−シクロプロピルアミノメチル−１−ピロリジニル）キノロンカルボン酸誘導体
WO2013069297A1 (ja) * 2011-11-10 2013-05-16 杏林製薬株式会社 ７－｛（３s、４s）－３－［（シクロプロピルアミノ)メチル］－４－フルオロピロリジン－1－イル｝－６－フルオロ－１－（２－フルオロエチル）－８－メトキシ－４－オキソ－１、４－ジヒドロキノリン－３－カルボン酸の結晶
WO2013145750A1 (ja) * 2012-03-29 2013-10-03 杏林製薬株式会社 カプセル製剤
WO2013145749A1 (ja) * 2012-03-29 2013-10-03 杏林製薬株式会社 カプセル製剤

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6018334B2 (ja) * 2014-10-23 2016-11-02 杏林製薬株式会社 固形医薬組成物

Also Published As

Publication number Publication date
US9687453B2 (en) 2017-06-27
JP2015110646A (ja) 2015-06-18
CA2910121A1 (en) 2014-10-30
CN105338981B (zh) 2017-10-13
EP2990039A1 (en) 2016-03-02
JP6689333B2 (ja) 2020-04-28
EP2990039A4 (en) 2017-02-22
JP6397778B2 (ja) 2018-09-26
WO2014174847A1 (ja) 2014-10-30
CN105338981A (zh) 2016-02-17
JP2018199713A (ja) 2018-12-20
JPWO2014174847A1 (ja) 2017-02-23
US20160074330A1 (en) 2016-03-17

Similar Documents

Publication Publication Date Title
JP6397778B2 (ja) 固形医薬組成物
JP5651812B1 (ja) 固形医薬組成物
EP3606511A1 (en) Pharmaceutical composition comprising lenvatinib mesylate
JP6349306B2 (ja) 錠剤
EP3860606B1 (en) Pharmaceutical composition comprising lenvatinib esylate or tosylate
JP4759102B2 (ja) 経口投与用医薬組成物
JPWO2013145749A1 (ja) カプセル製剤
JP6063379B2 (ja) 固形医薬組成物
JP6018334B2 (ja) 固形医薬組成物
JPWO2020045607A1 (ja) 経口投与用医薬組成物
JPWO2016063544A1 (ja) 固形医薬組成物

Legal Events

Date Code Title Description
TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20150210

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20150213

R150 Certificate of patent or registration of utility model

Ref document number: 5700740

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R153 Grant of patent term extension

Free format text: JAPANESE INTERMEDIATE CODE: R153

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313111

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250